Evidence map›Paper›PMID 23943230›Full record

ReviewCurrent diabetes reports2013

Continuous glucose monitoring: current use and future directions.

Daniel DeSalvo, Bruce Buckingham

Abstract readReview
In one paragraph

Review in Current diabetes reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Trial
  2. Article
  3. Controlling Glycemic Variability in Non-diabetic Sepsis Patients: A Step toward Precision in Critical Care.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2025
    Article
  4. Article
  5. Continuous Glucose Monitoring as a Matter of Justice.HEC forum : an interdisciplinary journal on hospitals' ethical and legal issues · 2021
    Article
  6. Article
  7. Data-Driven Insights on Behavioral Factors that Affect Diabetes Management.Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference · 2020
    Article
  8. Article
  9. Article
  10. Glucose sensing technology-current practice?Irish journal of medical science · 2019
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Designing an artificial pancreas architecture: the AP@home experience.Medical & biological engineering & computing · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Daniel DeSalvoDepartment of Pediatric Endocrinology and Diabetes, Stanford Medical Center, G-313, 300 Pasteur Drive, Stanford, CA, 94305, USA.
Bruce Buckingham

Funding

XOLAIR IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS WITH FOOD ALLERGYM01RR000070 · NCRR · STANFORD UNIVERSITY · PI RASGON, NATALIE L · 1985 to 2008
$32.4M
Prevention of Nocturnal Hypoglycemia: Effect on Neurologic Outcome in ToddlersU10HD041908 · NICHD · STANFORD UNIVERSITY · PI BUCKINGHAM, BRUCE A · 2001 to 2011
$3.5M
NCRR NIH HHS M01 RR000070NICHD NIH HHS U10 HD041908
6 · The paper itself

Abstract

Continuous glucose monitoring (CGM) is an emerging technology that provides a continuous measure of interstitial glucose levels. In addition to providing a more complete pattern of glucose excursions, CGMs utilize real-time alarms for thresholds and predictions of hypo- and hyperglycemia, as well as rate of change alarms for rapid glycemic excursions. CGM users have been able to improve glycemic control without increasing their risk of hypoglycemia. Sensor accuracy, reliability, and wearability are important challenges to CGM success and are critical to the development of an artificial pancreas (or closed-loop system).

Indexed as

Blood Glucose Self-MonitoringFeasibility StudiesHealth Knowledge, Attitudes, PracticeHumansHypoglycemiaReproducibility of Results

Identifiers

PMID23943230
PMCPMC5164922

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.